Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trials

Documenti analoghi

• The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications. 1. Use of the EEG in drug development and characteristics of the model
  di: Dorothée Kasteleijn‐Nolst Trenité, et al.
  Pubblicazione: (2025)
• The upside of epilepsy: Theories of an evolutionary paradox
  di: Alyssa Ailion, et al.
  Pubblicazione: (2025)
• Pharmacodynamic interactions between seletracetam and antiseizure comedications in the human photosensitivity model
  di: Wolfgang Löscher, et al.
  Pubblicazione: (2025)
• Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof‐of‐concept clinical study
  di: Karin Thevissen, et al.
  Pubblicazione: (2025)
• Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development
  di: Meir Bialer, et al.
  Pubblicazione: (2024)